Alzheimer's Society and the Bupa Foundation today announce the launch of a ground-breaking partnership to boost research into dementia and its causes.
The two charities are together launching a £1.5million fund to support research into an issue that is affecting more and more people in the UK and internationally.
Dr Andrew Vallance-Owen, deputy chairman of the Bupa Foundation said:Dementia is a cruel condition which robs people of their memories - and in future more and more people will be living with the condition or be affected by it. £1.5m will make a real difference and help advance our knowledge of dementia.
The new fund aims to encourage partnership and collaboration between institutions to maximize expert involvement and to share knowledge and best practice. Researchers can apply for grants ranging from £100,000 to £750,000 and the fund is also open to applications from researchers in Australia, China, Denmark, Hong Kong, India, New Zealand, Saudi Arabia, Spain and Thailand, as well as the UK.
Neil Hunt, chief executive of Alzheimer's Society said:Dementia research is seriously under-funded. Much more needs to be invested if we are to see the same advancements in dementia care and treatment as we have seen for cancer. By delaying the onset of dementia by just five years we could halve the number of deaths from the condition, saving 30,000 lives a year, but without progress in research the economic cost of the disease is likely to rise to £27 billion by 2018.
This research fund between Alzheimer's Society and the Bupa Foundation charity coincides with a series of joint initiatives involving Alzheimer's Society and Bupa. Alzheimer's Society has been named the nominated charity for the Bupa Great Runs series - which includes the world's largest half marathon, the Bupa Great North Run. Alzheimer's Society and Bupa have also worked together to create the pioneering Dementia Champions programme for Bupa's specialist dementia care homes.
Alzheimer's Society currently invests more than £1.6 million a year in dementia research and has funded over 100 research projects in leading scientific institutions across the UK.
Since being established in 1979 The Bupa Foundation - an independent medical research charity to fund research to prevent, relieve and cure sickness and ill health - has donated around £26 million, the vast majority of which has gone to medical research teams in the public sector.
The closing date for applications is 28 February 2010. Grants would be awarded in line with guidelines issued by the Association of Medical Research Charities (AMRC).
For details on how to apply go to: www.bupafoundation.co.uk or www.alzheimers.org.uk/research.
More information on the £1.5m fund:
- The topics that may be considered for funding in the areas of cause, cure, care and prevention include:
- Epidemiology of all forms of dementia
- The causes of dementia and mechanism of disease progression
- The causal relationship between genetics and lifestyle factors predisposing people to dementia
- Prevention, diagnosis and treatment of dementia
- Slowing the progress of dementia
- Developing (non-embryonic) stem cell therapies with translational benefits for people with dementia
- Evidence for dietary supplements or complementary therapies as an alternative to drugs
- Improving Quality of life for people with dementia in their own homes or care homes
- How to best train staff in all health sectors, at all levels, in communicating with, understanding the needs of, and caring for people with dementia
- Management of anxiety, agitation and other behavioural symptoms, without the use of antipsychotic drugs
- The impact of acute hospitalization of people with dementia
Ends
Contact Us
Bupa's purpose is to help people lead longer, healthier, happier lives. A leading international healthcare group, we offer personal and company health insurance, run care homes for older people and hospitals, and provide workplace health services, health assessments and chronic disease management services, including health coaching, and home healthcare.
With no shareholders, we invest our profits to provide more and better healthcare, and fulfill our purpose. We are committed to making quality, patient-centred, affordable healthcare more accessible in the areas of wellness, chronic disease management and ageing.
Employing more than 52,000 people, Bupa has operations around the world, principally in the UK, Australia, Spain, New Zealand and the USA, as well as Hong Kong, Thailand, Saudi Arabia, India, China and across Latin America.
For more information, visit www.bupa.com.
